Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2.
BACKGROUND
Notch receptors are normally cleaved during maturation by a furin-like protease at an extracellular site termed S1, creating a heterodimer of non-covalently associated subunits. The S1 site lies within a key negative regulatory region (NRR) of the receptor, which contains three highly conserved Lin12/Notch repeats and a heterodimerization domain (HD) that interact to prevent premature signaling in the absence of ligands. Because the role of S1 cleavage in Notch signaling remains unresolved, we investigated the effect of S1 cleavage on the structure, surface trafficking and ligand-mediated activation of human Notch1 and Notch2, as well as on ligand-independent activation of Notch1 by mutations found in human leukemia.


RESULTS
The X-ray structure of the Notch1 NRR after furin cleavage shows little change when compared with that of an engineered Notch1 NRR lacking the S1-cleavage loop. Likewise, NMR studies of the Notch2 HD domain show that the loop containing the S1 site can be removed or cleaved without causing a substantial change in its structure. However, Notch1 and Notch2 receptors engineered to resist S1 cleavage exhibit unexpected differences in surface delivery and signaling competence: S1-resistant Notch1 receptors exhibit decreased, but detectable, surface expression and ligand-mediated receptor activation, whereas S1-resistant Notch2 receptors are fully competent for cell surface delivery and for activation by ligands. Variable dependence on S1 cleavage also extends to T-ALL-associated NRR mutations, as common class 1 mutations display variable decrements in ligand-independent activation when introduced into furin-resistant receptors, whereas a class 2 mutation exhibits increased signaling activity.


CONCLUSIONS
S1 cleavage has distinct effects on the surface expression of Notch1 and Notch2, but is not generally required for physiologic or pathophysiologic activation of Notch proteins. These findings are consistent with models for receptor activation in which ligand-binding or T-ALL-associated mutations lead to conformational changes of the NRR that permit metalloprotease cleavage.
Gordon
Wendy R
WR
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Vardar-Ulu
Didem
D
L'Heureux
Sarah
S
Ashworth
Todd
T
Malecki
Michael J
MJ
Sanchez-Irizarry
Cheryll
C
McArthur
Debbie G
DG
Histen
Gavin
G
Mitchell
Jennifer L
JL
Aster
Jon C
JC
Blacklow
Stephen C
SC
D000595:Amino Acid Sequence; D019281:Dimerization; D045683:Furin / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009154:Mutation; D019906:Nuclear Magnetic Resonance, Biomolecular; D011487:Protein Conformation; D051881:Receptor, Notch1 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D051883:Receptor, Notch2 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction; D014961:X-Ray Diffraction
C497761:NOTCH1 protein, human; C497764:NOTCH2 protein, human; D051881:Receptor, Notch1; D051883:Receptor, Notch2; D045683:Furin
Annu Rev Pathol. 2008;3:587-613
18039126
Science. 2004 Oct 8;306(5694):269-71
15472075
Dev Biol. 2001 Jan 15;229(2):494-502
11150244
Nature. 1999 Apr 8;398(6727):522-5
10206646
J Biol Chem. 1997 Apr 25;272(17):11336-43
9111040
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1683-8
8643690
Nat Rev Mol Cell Biol. 2006 Sep;7(9):678-89
16921404
Genes Dev. 1993 Oct;7(10):1949-65
8406001
J Biol Chem. 1998 Oct 23;273(43):27779-85
9774386
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8108-12
9653148
Biochemistry. 2001 May 29;40(21):6275-83
11371189
Methods Mol Biol. 2004;278:313-52
15318002
Mech Dev. 2002 Jul;115(1-2):41-51
12049766
Nature. 1999 Apr 8;398(6727):518-22
10206645
Development. 2000 Jul;127(14):3185-95
10862754
Mol Cell. 2000 Feb;5(2):207-16
10882063
Blood. 2009 Apr 30;113(18):4381-90
19075186
Nat Struct Mol Biol. 2007 Apr;14(4):295-300
17401372
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
Mol Cell Biol. 2006 Jun;26(12):4642-51
16738328
Cell. 1991 Nov 15;67(4):687-99
1657403
Mol Cell Biol. 2000 Mar;20(5):1825-35
10669757
Nat Neurosci. 2000 Jan;3(1):30-40
10607392
Biochem J. 1996 Jan 1;313 ( Pt 1):71-6
8546712
Adv Virus Res. 2005;64:231-61
16139596
Nature. 1999 Apr 8;398(6727):525-9
10206647
Mol Cell Biol. 2004 Nov;24(21):9265-73
15485896
J Biol Chem. 1999 Dec 17;274(51):36801-7
10593990
J Cell Biol. 2007 Feb 12;176(4):445-58
17296795
J Biol Chem. 2005 Aug 26;280(34):30158-65
15994325
J Biol Chem. 2008 Mar 21;283(12):8046-54
18182388
Mol Cell. 2000 Feb;5(2):197-206
10882062
Cell. 1997 Jul 25;90(2):281-91
9244302
Nature. 1990 Jul 12;346(6280):197-9
2164160